75 related articles for article (PubMed ID: 20193423)
1. [Identification and characterization of ovarian cancer stem-like cells from primary tumor.].
Lai DM; Liu T; Huang Y; Wang LH; Zhang J; Cheng WW
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):936-40. PubMed ID: 20193423
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas.
He QZ; Luo XZ; Wang K; Zhou Q; Ao H; Yang Y; Li SX; Li Y; Zhu HT; Duan T
Cell Physiol Biochem; 2014; 33(1):173-84. PubMed ID: 24504111
[TBL] [Abstract][Full Text] [Related]
4. Characterization of primary ovarian cancer cells in different culture systems.
Liu T; Cheng W; Lai D; Huang Y; Guo L
Oncol Rep; 2010 May; 23(5):1277-84. PubMed ID: 20372841
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
[No Abstract] [Full Text] [Related]
6. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
[TBL] [Abstract][Full Text] [Related]
7. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
8. The cultivation and identification of tumor stem cells from neuroblastoma derived tumor spheres.
Liu QX; Tang JY; Cai JY; Yin MZ; Li BS
Chin J Cancer; 2010 Dec; 29(12):1012-7. PubMed ID: 21114922
[TBL] [Abstract][Full Text] [Related]
9. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma.
Ma B; Lei X; Guan Y; Mou LS; Yuan YF; Yue H; Lu Y; Xu GT; Qian J
Oncol Rep; 2011 Jul; 26(1):135-43. PubMed ID: 21573498
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
Zhang S; Balch C; Chan MW; Lai HC; Matei D; Schilder JM; Yan PS; Huang TH; Nephew KP
Cancer Res; 2008 Jun; 68(11):4311-20. PubMed ID: 18519691
[TBL] [Abstract][Full Text] [Related]
12. Establishment of human ovarian serous carcinomas cell lines in serum free media.
Pan Z; Hooley J; Smith DH; Young P; Roberts PE; Mather JP
Methods; 2012 Mar; 56(3):432-9. PubMed ID: 22445873
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma.
Lee M; Nam EJ; Kim SW; Kim S; Kim JH; Kim YT
Int J Gynecol Cancer; 2012 Nov; 22(9):1489-96. PubMed ID: 23095773
[TBL] [Abstract][Full Text] [Related]
14. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
15. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
16. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
19. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
20. Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties.
Gou S; Liu T; Wang C; Yin T; Li K; Yang M; Zhou J
Pancreas; 2007 May; 34(4):429-35. PubMed ID: 17446842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
